Nat2 Gene - Toxicology

Relevant Publications

Towards pharmacogenomics-guided tuberculosis (TB) therapy: N-acetyltransferase-2 genotypes among TB-infected Kenyans of mixed ethnicity.

Issue Release: 2024

Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity.

Issue Release: 2024

Discovery of Oncogenic Mediator Genes in Rectal Cancer Chemotherapy Response using Gene Expression Data from Matched Tumor and Patient-Derived Organoid.

Issue Release: 2024

Pharmacogenetic Analysis of an 8-Year Old Girl with Reye Syndrome Associated with Use of Naproxen.

Issue Release: 2024

Pharmacogenetic Study of Drugs Affecting Mycobacterium tuberculosis.

Issue Release: 2024

N-acetyltransferase Gene Variants Involved in Pediatric Idiosyncratic Drug-Induced Liver Injury.

Issue Release: 2024

Interaction between Caffeine Consumption & Genetic susceptibility in Parkinson\'s disease: a systematic review.

Issue Release: 2024

N-Acetyltransferase 2 gene polymorphism and its serum levels in vitiligo patients.

Issue Release: 2024

Association of the cytochrome P450 and arylamine N-acetyltransferase gene polymorphisms with the incidence of head and neck cancer in Polish populatio.

Issue Release: 2023

Evaluating interactions of polygenic risk scores and NAT2 genotypes with tobacco smoking in bladder cancer risk.

Issue Release: 2023

Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation.

Issue Release: 2023

Association of NAT2, GSTT1, and GSTM1 gene polymorphisms withprostate cancer risk in Bangladeshi population.

Issue Release: 2023

A case-control study in NAT2 gene polymorphism studies in patients diagnosed with acute myeloid leukemia.

Issue Release: 2023

The impact of IDH and NAT2 gene polymorphisms in acute myeloid leukemia risk and overall survival in an Arab population: A case-control study.

Issue Release: 2023

WGCNA combined with machine learning to find potential biomarkers of liver cancer.

Issue Release: 2023

N-acetyltransferase 2 haplotype modifies risks for both dyslipidemia and urinary bladder cancer.

Issue Release: 2023

Discovery of a novel genetic variant in the N-acetyltransferase2 (NAT2) gene that is associated with bladder cancer risk.

Issue Release: 2023

NAT2 global landscape: Genetic diversity and acetylation statuses from a systematic review.

Issue Release: 2023

Non-coding and intergenic genetic variants of human arylamine -acetyltransferase 2 (NAT2) gene are associated with differential plasma lipid and cholesterol levels and cardiometabolic disorders.

Issue Release: 2023

Human Arylamine -Acetyltransferase 1 (NAT1) Knockout in MDA-MB-231 Breast Cancer Cell Lines Leads to Transcription of NAT2.

Issue Release: 2022

What Happens During Oral Exposure?

What Role Does Genetic Susceptibility Play?

How is Polystyrene Produced?

What are the Long-term Effects of Gastrointestinal Damage?

How Does Real-Time Analysis Work?

What Are the Principles of Toxicology?

What Are the Challenges in Achieving Physiological Relevance?

What Are the Limitations of Detoxifying Agents?

What is the Future of Therapeutic Toxicology?

Are Bio-Based Resins Safe for Human Use?

Partnered Content Networks

Relevant Topics